Tarsus Pharmaceuticals, Inc. TARS Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s free cash flow yield?
- Tarsus Pharmaceuticals, Inc. (TARS) reported free cash flow yield of -4.8% in Q2 2025.
- How has Tarsus Pharmaceuticals, Inc.'s free cash flow yield changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s free cash flow yield increased by 63.6% year-over-year, from -13.1% to -4.8%.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s free cash flow yield?
- Over 3 years (2020 to 2024), Tarsus Pharmaceuticals, Inc.'s free cash flow yield has grown at a 15.9% compound annual growth rate (CAGR), from -2.6% to -4%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.